NCT01057186Unknown不适用
Hypophosphatemic Rickets in Norway
Haukeland University Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2009年12月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- Growth
研究概览
简要总结
The purpose of the study is to do a follow-up survey of all individuals with hereditary hypophosphatemia in Norway, focusing on manifestations in childhood and adolescence. The investigators also want to study phenotype-genotype associations, and look for new genes, in all forms of hereditary hypo and hyperphosphatemia.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •All patients in the Norwegian population with hereditary hypophosphatemia, with or without rickets
- •Patients in the Norwegian population with hereditary hyperphosphatemia
排除标准
- 未提供
研究组 & 干预措施
hereditary hypophosphatemia
Norwegian patients with hereditary hypophosphatemia.
干预措施: Alfacalcidol; phosphate. (Dietary Supplement)
Hereditary hyperphosphatemia
Norwegian patients with hereditary hyperphosphatemia (hyperphosphatemic familial tumoral calcinosis and hyperphosphatemia hyperostosis syndrome).
干预措施: Sevelamer (Drug)
结局指标
主要结局
Growth
时间窗: Up to 18 years
Change i height z-score from time of diagnosis to last registered consultation.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Characteristics of Hypophosphatasia in Adult Patients in RheumatologyHypophosphatasiaNCT06161142University of Bonn60
已完成
不适用
Unraveling Genetics of HypoPhosPhatasia (HPP Genetics)HypophosphatasiaNCT04925804CENTOGENE GmbH Rostock16
已完成
不适用
Hypoparathyroidism in DenmarkHypoparathyroidismNCT01498341University of Aarhus1,000
招募中
不适用
Natural History Study of Patients With Hypophosphatasia (HPP)HypophosphatasiaNCT02237625Duke University200
招募中
不适用
A Prospective Sub-Study of the Global Hypophosphatasia RegistryHypophosphatasiaNCT05234567Alexion Pharmaceuticals, Inc.30